Empowering Small Molecule Drug Discovery by Automatic DEL Screening

In this webinar, our expert speakers showcase our automatic DNA-encoded library (DEL) screening device, DELman.

DNA-encoded library technology has proven to be a powerful tool for drug discovery. There are now several DEL-derived candidates in clinical stage. DEL enables researchers to explore vast chemical space with millions to billions of compounds. With DELman and other self-service data analysis tools, we show how researchers can wield DEL screens in appointed scenarios to obtain stable and reliable screening outcomes.


← Return to Resources

Related Content

In addition to identifying chemical starting points for early drug discovery processes, DNA-encoded library (DEL) technology has now expanded to...


Despite the resurgence of interest in peptide therapeutics for historically “undruggable” targets, de novo discovery of peptide ligands remains a...

← View all DNA-Encoded Library (DEL) Resources
× peptide, amino acid

Contact An Expert Today!